scispace - formally typeset
G

Giuseppe Paolisso

Researcher at Seconda Università degli Studi di Napoli

Publications -  518
Citations -  36557

Giuseppe Paolisso is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 85, co-authored 479 publications receiving 33028 citations. Previous affiliations of Giuseppe Paolisso include National Institutes of Health & University of Udine.

Papers
More filters
Journal ArticleDOI

Cellular resistance to homocysteine: a key for longevity.

Bulent Mutus, +8 more
- 01 Oct 2000 - 
Journal Article

Low fasting and insulin-mediated intracellular magnesium accumulation in hypertensive patients with left ventricular hypertrophy: role of insulin resistance.

Giuseppe Paolisso, +5 more
- 01 Mar 1995 - 
TL;DR: It is concluded that hypertensive patients with LVH compared with those without LVH have a lower intracellular magnesium content due to a higher degree of insulin resistance.
Journal ArticleDOI

PUFA supplements and type 2 diabetes in the elderly.

Angela Marie Abbatecola, +2 more
- 30 Nov 2009 - 
TL;DR: Specific dietary fat intake patterns and the development of insulin resistance and type 2 diabetes, the effects of PUFA supplementation on glucose metabolism, diabetic dyslipidemia and cardiovascular disease, and the potential advantages of PU FA supplementation on cognitive decline and physical disability in the elderly are addressed.
Journal ArticleDOI

Sodium salicylate restores the impaired insulin response to glucose and improves glucose tolerance in heroin addicts.

Dario Giugliano, +7 more
- 01 Jul 1987 - 
TL;DR: It is demonstrated that the two prostaglandin synthesis inhibitors can restore the impaired B-cell response to glucose in heroin addicts to normal, indicating that this response is not lost but is inhibited by heroin itself or by other substances, perhaps by the endogenous prostag landins.
Journal ArticleDOI

Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

Marco Bertolotti, +391 more
- 15 Mar 2017 - 
TL;DR: In this in-hospital cohort, the use of lipid-lowering agents was mainly driven by patients’ clinical history, most notably the presence of clinically overt manifestations of atherosclerosis.